---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-22-000059"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T05:59:56.020541+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "low"
source: SEC EDGAR
---

# Haemonetics files 8-K for Q2 FY2023 results; filing lacks specific financial figures

## Summary
- Company issued press release for Q2 ended October 1, 2022 and first half FY2023 results.
- Filing only references Exhibit 99.1; actual financial data not included in provided text.
- Confidence in event detail is low due to absence of numbers in this filing.

## SEC filing metadata
- accession: 0000313143-22-000059
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: low
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314322000059/0000313143-22-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314322000059/hae-20221107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-22-000059
- JSON: https://secwatch.observer/filing/0000313143-22-000059.json
- Plain text: https://secwatch.observer/filing/0000313143-22-000059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.